Clinical Trials Browser

Interventional × Glioblastoma × carotuximab × Clear all

NCT01564914 2019-06-12

105GM201

Phase 2 Completed

22 enrolled 11 charts

Glioblastoma

NCT01648348 2018-05-23

Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme

Phase 1/2 Completed

116 enrolled 17 charts

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma